All Miami Cancer Institute | Miami Cancer Institute | Baptist Health South Florida

Menu

Skip to main content

All Miami Cancer Institute

Submissions from 2018 2018

Retrospective review of oral oncolytic agent use within a community hospital, Alyssa Donadio, Moe Shwin, Maria Figueroa, and Michelle Lamarque

Synoptic Reporting: Evidence-Based Review and Future Directions, Andrew Renshaw, Mercy Mena-Allauca, and Edwin Gould

The Case for Proton Beam Therapy, Michael Chuong

Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?, Minesh Mehta and Rupesh Kotecha

Evaluation of Proton Therapy Accuracy Using a PMMA Phantom and PET Prediction Module, Wen Hsi

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool, Minesh Mehta

Understanding Pancreatic Diseases Using Animated Pancreas Patient: Informing Patients for Better Health Outcomes With Visual Formats of Learning, Andres Gelrud

Recent advances in managing brain metastasis, Rupesh Kotecha and Minesh Mehta

Abstract 17153: Trends in Coronary Revascularization Among Cancer Patients in the United States, 2005-2014, Muni Rubens, Anshul Saxena, Peter McGranaghan, Sankalp Das, Deborah Suarez, Brittany Puebla, Alexandra Guida, and Emir Veledar

A Real World Experience of the FAST-ED Based Pre-Hospital Stroke Triage System to Detect Large Vessel Occlusions, Ned Shashoua, Amy Starosciak, Jayme Strauss, and Felipe De Los Rios La Rosa

Dosimetric Impact of Large Displacement of the Metal Port of the Tissue Expander in Intensity Modulated Proton Therapy, Jen Yu, Jaafar Bennouna, and Minesh Mehta

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero

Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer, Minesh Mehta

Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study, Minesh Mehta

Robotic resection of Stage III lung cancer: an international retrospective study, Mark Dylewski

Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing, Rupesh Kotecha

Ten-Year Outcomes and Toxicity with Moderately Hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer, Rupesh Kotecha

Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus, Minesh Mehta

What is the evidence for the clinical value of SBRT in cancer of the cervix?, Minesh Mehta

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02, Manmeet Ahluwalia

Alcohol Consumption and Risk of Thyroid Cancer: A Population Based Case-Control Study in Connecticut, Robert Udelsman

Proton therapy patterns of care among pediatric and adult patients with CNS tumors, Rupesh Kotecha

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial, Minesh Mehta

Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres, Michael Chuong

Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma, Rupesh Kotecha